Tower Research Capital »

Galmed Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Galmed Pharmaceuticals

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 29500100050100150
Value ($)Share countHistorical GLMD position of Tower Research Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $187 59 3.19
2024-09-30 $1.2k 173 6.86

More positions owned by Tower Research Capital

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)

View all positions for Tower Research Capital

Top funds holding Galmed Pharmaceuticals

Schonfeld Strategic Advisors
Morgan Stanley
UBS Group
Tower Research Capital
Wells Fargo & Company
TSFG
SBI Securities
Federation des caisses Desjardins du Quebec
Advisor Group Holdings
Hanson McClain Advisors
Zrc Wealth Management
Dogwood Wealth Management

View all funds holding Galmed Pharmaceuticals